Intensive Care Anxiety in SARS-CoV-2 Patients

January 16, 2021 updated by: İLKE KÜPELİ, Derince Training and Research Hospital

Intensive Care Anxiety in SARS-CoV-2 (COVID 19) Patients

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Kocaeli̇
      • İ̇zmi̇t, Kocaeli̇, Turkey
        • Recruiting
        • Ilke Kupeli
        • Contact:
          • İLKE KÜPELİ

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Co-operative patients over 18 years of age, with COVID PCR + admission to intensive care unit, will be included in the study.

Description

Inclusion Criteria:

  • Above 18 years old
  • COVID PCR +,
  • admitted to intensive care,
  • conscious, cooperative patients

Exclusion Criteria:

  • Having hearing and speaking problems,
  • Can't speak Turkish or English,
  • who do not have the cognitive level to understand and answer the questions,
  • Communication problems such as dementia and Alzheimer's,
  • patients receiving sedation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hospital Anxiety Depression Measure
Behavioral: Hospital Anxiety Depression Measure
Hospital Anxiety Depression Measure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intensive care Anxiety
Time Frame: 3 month
Hospital Anxiety Depression scale
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Derince Training and Research Hospital

Investigators

  • Principal Investigator: ilke kupeli, Derince Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 17, 2021

Primary Completion (Anticipated)

April 1, 2021

Study Completion (Anticipated)

April 15, 2021

Study Registration Dates

First Submitted

January 15, 2021

First Submitted That Met QC Criteria

January 16, 2021

First Posted (Actual)

January 20, 2021

Study Record Updates

Last Update Posted (Actual)

January 20, 2021

Last Update Submitted That Met QC Criteria

January 16, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • derince TRH 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Hospital Anxiety Depression Measure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe